Similar companies
Vivos Therapeutics Monthly Web Traffic
Vivos Therapeutics’s website receives an estimated 9,000 monthly visits, up 12.5% over the past three months. Rising web traffic can indicate growing consumer interest and brand engagement, both of which tend to precede revenue growth.
At 9,000 monthly visits, Vivos Therapeutics trails industry peers like Boston Scientific (655,000) and Edwards Lifesciences (209,000).
How Web Traffic Impacts VVOS’s AI Score
Web traffic is a real-time read on consumer demand and brand engagement: for consumer-facing companies, a sustained change in website visits can precede changes in reported revenue. AltIndex feeds Vivos Therapeutics’s monthly visit estimates into the VVOS AI Score as one of 25+ alternative data signals, where traffic momentum is weighed against hiring, sentiment, and fundamentals.
For other growth metrics, see Vivos Therapeutics app downloads, Google Trends, Instagram followers, and LinkedIn headcount.
Month over Month
| Sep 2026 | 9,000 | |
| Aug 2026 | 15,000 | |
| Jul 2026 | 36,000 | |
| Jun 2026 | 8,000 | |
| May 2026 | 10,000 | |
| Apr 2026 | 11,000 |
Vivos Therapeutics Web Traffic: Frequently Asked Questions
Vivos Therapeutics's website receives approximately 9,000 monthly visits, based on AltIndex's estimate aggregated from the top web traffic data providers. This figure includes desktop and mobile visitors to the company's primary domain.
Vivos Therapeutics's web traffic is up 12.5% over the past three months. This is a significant change that may indicate shifting consumer interest.
Web traffic is a real-time indicator of consumer demand and brand engagement. For consumer-facing companies, declining website visits can precede revenue slowdowns. AltIndex tracks web traffic as one of 25+ signals in its AI Score model.
No single data point predicts a stock price on its own, but website traffic is a leading indicator: a sustained shift in Vivos Therapeutics's monthly visitors can show up before it reaches reported revenue. That is why AltIndex combines VVOS's web traffic trend with hiring, sentiment, app downloads, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Vivos Therapeutics underperforms its industry peers when it comes to Webpage traffic, ranking dead last.
Sign up and get more insights on Vivos Therapeutics and its Webpage performance.
See Vivos Therapeutics’s complete webpage traffic history
Sign up to unlock 1-year and all-time charts for VVOS, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
